Market Research Reports and Industry Reports

Stallergenes Greer plc (STAGR) - Financial and Strategic SWOT Analysis Review

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Stallergenes Greer plc (STAGR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Stallergenes Greer plc (Stallergenes Greer), formerly Ares Allergy Holdings plc is a biopharmaceutical company, which provides treatments for allergy-related respiratory diseases. The company develops diagnostic tests and products with principal focus on allergies. The company offers treatment for important respiratory diseases, which include severe rhino conjunctivitis and rhinitis, and allergic asthma. Stallergenes Greer provides allergen immunotherapy in various dosage forms including injectable or subcutaneous injections, liquid sublinguals and solid sublinguals. Its research and development activities involve development of candidate products, laboratory research, clinical development and regulatory activities. The company distributes its products to various countries in North America, Europe, Africa; Asia and in Australia. Stallergenes Greer is headquartered in London, the UK.

Stallergenes Greer plc Key Recent Developments

Aug 31,2017: Stallergenes Greer Reports Strong First Half 2017 Results and Narrows 2017 Financial Guidance
Jun 29,2017: Stallergenes Greer Announces Matthias Vogt as Chief Financial Officer
Mar 29,2017: Stallergenes Greer announces its 2016 full year results
Jan 31,2017: Stallergenes Greer Announces Resignation Of Chief Financial Officer
Jun 09,2016: Stallergenes Greer Announces Results Of 2016 Annual General Meeting

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Stallergenes Greer plc - Key Facts 5
Stallergenes Greer plc - Key Employees 6
Stallergenes Greer plc - Key Employee Biographies 7
Stallergenes Greer plc - Major Products and Services 8
Stallergenes Greer plc - History 9
Stallergenes Greer plc - Company Statement 10
Stallergenes Greer plc - Locations And Subsidiaries 11
Head Office 11
Other Locations & Subsidiaries 11
Section 2 Company Analysis 13
Stallergenes Greer plc - Business Description 13
Stallergenes Greer plc - SWOT Analysis 14
SWOT Analysis - Overview 14
Stallergenes Greer plc - Strengths 14
Stallergenes Greer plc - Weaknesses 15
Stallergenes Greer plc - Opportunities 16
Stallergenes Greer plc - Threats 17
Stallergenes Greer plc - Key Competitors 18
Section 3 Company Financial Ratios 19
Financial Ratios - Capital Market Ratios 19
Financial Ratios - Annual Ratios 20
Performance Chart 22
Financial Performance 22
Financial Ratios - Interim Ratios 23
Financial Ratios - Ratio Charts 24
Section 4 Companys Lifesciences Financial Deals and Alliances 25
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 25
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 26
Stallergenes Greer plc, Recent Deals Summary 27
Section 5 Companys Recent Developments 28
Jun 29, 2017: Stallergenes Greer Announces Matthias Vogt as Chief Financial Officer 28
Mar 29, 2017: Stallergenes Greer announces its 2016 full year results 29
Jan 31, 2017: Stallergenes Greer Announces Resignation Of Chief Financial Officer 31
Jun 09, 2016: Stallergenes Greer Announces Results Of 2016 Annual General Meeting 32
May 27, 2016: Update On Stallergenes Greer Manufacturing And Distribution Activities 33
Apr 27, 2016: Stallergenes Greer Announces Its 2015 Full Year Results 34
Apr 11, 2016: Daniel Smith Appointed Global Head Of Information Technology 39
Section 6 Appendix 40
Methodology 40
Ratio Definitions 40
About GlobalData 44
Contact Us 44
Disclaimer 44

List Of Tables


Stallergenes Greer plc, Key Facts 5
Stallergenes Greer plc, Key Employees 6
Stallergenes Greer plc, Key Employee Biographies 7
Stallergenes Greer plc, Major Products and Services 8
Stallergenes Greer plc, History 9
Stallergenes Greer plc, Subsidiaries 11
Stallergenes Greer plc, Key Competitors 18
Stallergenes Greer plc, Ratios based on current share price 19
Stallergenes Greer plc, Annual Ratios 20
Stallergenes Greer plc, Annual Ratios (Cont...1) 21
Stallergenes Greer plc, Interim Ratios 23
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 25
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 26
Stallergenes Greer plc, Recent Deals Summary 27
Currency Codes 40
Capital Market Ratios 40
Equity Ratios 41
Profitability Ratios 41
Cost Ratios 42
Liquidity Ratios 42
Leverage Ratios 43
Efficiency Ratios 43

List Of Figures


Stallergenes Greer plc, Performance Chart (2014 - 2016) 22
Stallergenes Greer plc, Ratio Charts 24
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 25
Stallergenes Greer plc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 26

Stallergenes Greer plc (STAGR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Stallergenes Greer plc (Stallergenes Greer), formerly Ares Allergy Holdings plc is a biopharmaceutical company, which provides treatments for allergy-related respiratory diseases. The company develops diagnostic tests and products with principal

USD 250View Report

Stallergenes Greer plc (STAGR) - Financial and Strategic SWOT Analysis Review

Stallergenes Greer plc (STAGR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125View Report

Stallergenes Greer plc (STAGR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Stallergenes Greer plc (Stallergenes Greer), formerly Ares Allergy Holdings plc is a biopharmaceutical company, which provides treatments for allergy-related respiratory diseases. The company develops diagnostic tests and products with principal

USD 250View Report

Stallergenes Greer plc Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Stallergenes Greer plc Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT

USD 200View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
Country Code.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 125
  • Site Licence    USD 250
  • Enterprise Wide Licence    USD 375
$ 125

Reports Details

Published Date : Aug 2017
No. of Pages :44
Country :United Kingdom
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube